sunitinib stada
stada arzneimittel ag - sunitinibas - kietosios kapsulės - 12,5 mg - sunitinib
sunitinib stada
stada arzneimittel ag - sunitinibas - kietosios kapsulės - 25 mg - sunitinib
sunitinib stada
stada arzneimittel ag - sunitinibas - kietosios kapsulės - 37,5 mg - sunitinib
sunitinib stada
stada arzneimittel ag - sunitinibas - kietosios kapsulės - 50 mg - sunitinib
sunitinib viasana
viasana, uab - sunitinibas - kietosios kapsulės - 12,5 mg - sunitinib
sutent
pfizer limited - sunitinibas - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - antinavikiniai vaistai - gastrointestinal stromal tumour (gist)sutent is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib mesilate treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sutent is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sutent is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours with disease progression in adults. experience with sutent as first-line treatment is limited (see section 5.
suphrex
lv system service sia - sunitinibas - kietosios kapsulės - 50 mg - sunitinib
suphrex
lv system service sia - sunitinibas - kietosios kapsulės - 12,5 mg - sunitinib
klertis
egis pharmaceuticals plc - sunitinibas - kietosios kapsulės - 12,5 mg - sunitinib
klertis
egis pharmaceuticals plc - sunitinibas - kietosios kapsulės - 25 mg - sunitinib